Sol-Gel - SLGL Net earnings per share for the last four quarters

Sol-Gel (SLGL) - corporate logo

Sol-Gel Technologies (SLGL) generates revenue by licensing its innovative active component protection system for dermatology. Leveraging patents for silica microcapsules, the company maintains strong pricing power. The current profit figure stands at -61.80. This price chart illustrates a phase of product line expansion and the development of R&D projects aimed at securing new licensing fees.

SLGL: Sol-Gel Technologies Ltd. Earnings per share for the last twelve months 02/11/2024 - 11/14/2026

SLGL (Sol-Gel): analytical breakdowns and indicator data

- current quotes and average value forecast:
Fundamental valuation:SLGL sol-gel.com
Core merchandise of Sol-Gel Technologies, Ltd.

Investors use this metric to evaluate the efficiency of profit scaling by analyzing the trend of net income per share over a rolling year. The calculation captures the percentage change in EPS (TTM), which for Sol-Gel Technologies (SLGL) reflects the stability of royalties from licensing agreements, while the GURU.Markets tool visualizes the resilience of this partnership model through a clear indicator of annual net income per share (TTM) growth.